Cancer Vaccines Set to Make Major Impact on Cancer Market :: Business Articles and Info

Thursday, 21st August 2008

home about authors news books xml feed sitemap privacy contact us

There is 1 user online

make home page

Books and Reading
Business Education
Business Industry
Business Services and Assistants
Business Technology
Corporate Companies
Current Events
E-Commerce and Internet
Economics
Employment and Opportunities
Finances
International Business
Investing
Management Editorials
Partnerships and Affiliate Programs
Promotion and Marketing
Seminars and Salesmanship
Small/Home Business
Statistics
Tax Related
The Stock Market
Tips and Strategies
Tools for Business

Our Newsletter

Other Resources

For other sources of business news, tips, and information, visit our resources page

Submit an Article

Would you like to have your article posted?

More info on business issues

Cancer Vaccines Set to Make Major Impact on Cancer Market
Added: 01/05/2005 Type: Summary Viewed: 667 time(s) [ Not Rated Yet ]

How would you rate this article: Bad Good Go »

Printer Friendly Version

Cancer Vaccines Set to Make Major Impact on Cancer Market

January 5, 2005 -- Vaccines represent fresh new treatment options for patients diagnosed with melanoma, prostate cancer, colorectal cancer, breast cancer, lung cancer, pancreatic cancer, and other life-threatening cancers. There are currently over twenty Phase III trials ongoing for various indications and new approvals may come as early as 2005.

This report includes the latest clinical data and analysis concerning the leading vaccines and the companies making them, allowing the reader to benchmark the competition and determine need in this growing field.

In addition, financial forecasts are provided for vaccines set to make an impact on distinct cancer markets. Moreover, their upcoming market entrance is discussed within the context of current and future biologic and small-molecule competition.

Therapeutic cancer vaccines have the potential to strengthen the body's natural defenses against cancers that have already developed. These vaccines may thus, prevent the further growth of existing cancers, prevent recurrence of treated cancers, or kill cancer cells not killed by other treatments.

This new 232-page report provides an overview of the emerging market for cancer vaccines and measures their potential impact on a wide range of cancer markets. It is designed to provide the information, insight, and analysis necessary to an understanding of how cancer vaccines will impact the biotech and pharmaceutical marketplace. Those in the field of cancer therapy will want to read this report in order to better understand where and how vaccines will make a difference in future cancer therapy.

Cancer Vaccines: Measuring Market Potential
• Gauges the potential of key vaccine products nearing commercialization.
• Analyzes the results of key clinical trials as a means of determining future success in the market.
• Forecasts financial growth of the cancer vaccine market through 2010.
• Assesses the competition from cytotoxics and other biologics in six key cancer markets.
• Provides valuable data concerning patient populations, survival rates, and global epidemiology
• Identifies and discusses trends and issues that will have a significant impact on the cancer vaccine market.
• Profiles the leading companies in the field and provides valuable information and analysis concerning their lead vaccine candidates.

Contact:
Sales Department
952-474-5203
www.arrowheadpublishers.com

Article Pages: 1

Article Comments

Add Comment |

View All (0)

There are currently no comments for this article.

Advanced Search


More Resources
Become a Day Trader Early Warning Services ecommerce shopping cart Find the Perfect Job Affiliate With Us